🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, claiming the firms hid alleged dangers that the medication created to children's cognitive development.

This legal action follows thirty days after Donald Trump promoted an unverified association between using acetaminophen - also known as paracetamol - while pregnant and autism spectrum disorder in offspring.

The attorney general is taking legal action against Johnson & Johnson, which once produced the medication, the only pain reliever approved for women during pregnancy, and Kenvue, which now manufacturers it.

In a statement, he claimed they "deceived the public by making money from suffering and promoting medication without regard for the risks."

Kenvue says there is lacking scientific proof tying acetaminophen to autism.

"These corporations lied for decades, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, stated.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its online platform, Kenvue also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a established connection between using paracetamol and autism spectrum disorder."

Organizations acting on behalf of doctors and medical practitioners share this view.

The leading OB-GYN organization has declared acetaminophen - the key substance in acetaminophen - is among limited choices for women during pregnancy to manage discomfort and fever, which can pose major wellness concerns if not addressed.

"In over twenty years of investigation on the utilization of paracetamol in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any period of pregnancy results in brain development issues in young ones," the group said.

The lawsuit references latest statements from the previous government in arguing the medication is reportedly hazardous.

In recent weeks, Trump raised alarms from public health officials when he instructed expectant mothers to "fight like hell" not to take Tylenol when ill.

Federal regulators then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

The Health Department head RFK Jr, who manages the FDA, had pledged in April to undertake "a massive testing and research effort" that would determine the source of autism spectrum disorder in a short period.

But experts cautioned that finding a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a type of enduring cognitive variation and impairment that impacts how persons perceive and interact with the world, and is identified using physician assessments.

In his court filing, Paxton - who supports Trump who is campaigning for the Senate - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the science" around paracetamol and autism spectrum disorder.

This legal action seeks to make the firms "eliminate any marketing or advertising" that claims acetaminophen is reliable for expectant mothers.

This legal action echoes the concerns of a assembly of guardians of young ones with autism and ADHD who sued the manufacturers of Tylenol in two years ago.

Judicial authorities dismissed the lawsuit, stating studies from the parents' expert witnesses was inconclusive.